Ganga Hospital Scoring System In Type-IIIA/B Open Tibial Fractures

Status Not yet recruiting

Clinical Trial Summary

The aim of this study is to assess interobserver reliability, sensitivity for amputation, and specificity for salvage of GHS in type-III injuries with open tibial fractures and predict the potential number of inpatient days, secondary procedures that would be required, and the rate of infection

Clinical Trial Description

Open fractures are usually high-energy injuries that can lead to life-threatening multiple injuries. It is classified as an orthopaedic emergency, and successful treatment depends on a thorough assessment and prompt treatment of the patient and wound. With the rise in severe open tibia injuries, an ideal scoring system with high specificity and sensitivity for predicting limb salvage is required. A misdiagnosis can lead to unnecessary amputations or salvage operations. A variety of scoring methods have been described for limb salvaging. The Gustilo and Anderson classification system is still the most used. Following the original classification, typeIII injuries were subdivided into type-IIIA, which denoted adequate soft-tissue coverage of the fracture despite extensive skin loss, type-IIIB, which denoted extensive soft-tissue loss, periosteal stripping, and bone exposure; and type-IIIC, which denoted an open fracture with an associated arterial injury that required repair. It has the limitations of a low intra and inter-observer agreement rate, low specificity and sensitivity to salvage and ambulation, and an inability to predict functional results in the care of Type IIIB injuries. The Ganga Hospital Score (GHS) is an open injury score developed from a high-volume trauma center that treats more than 600 open lower-limb fractures each year, far higher than a typical major trauma center in the United Kingdom. Following three clinical trials, the score was developed and has been shown to accurately predict whether a limb can be saved or must be amputated. The scoring system's nature, which takes into account particular injuries to the bone, skin, and musculotendinous units, as well as comorbid factors, has also been expanded to advise wound treatment. In medicine, scoring systems are used to rate the severity of an illness, predict the outcome, and aid in management decisions. In open injuries, an ideal score would have a sensitivity of 100%, with all limbs requiring amputation scoring at or above the threshold value, and a specificity of 100%, with all limbs that can be preserved scoring below the threshold value. Because these injuries are frequently complex clinical conditions, this is challenging to achieve. Although it is preferable to err on the side of high specificity such that only a small percentage of salvageable limbs score over the amputation threshold, high sensitivity is also necessary to limit the number of secondary amputations. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05435261
Study type	Observational
Source	Assiut University
Contact	Mohamed Mahmoud Abdelkarem, M.B.B.CH
Phone	01017781468
Email	Mohamed.20134306@med.au.edu.eg
Status	Not yet recruiting
Phase
Start date	December 1, 2022
Completion date	May 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00512434` - Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture	N/A
Enrolling by invitation	`NCT06055712` - Antibiotic Prophylaxis in Pediatric Open Fractures	Phase 4
Terminated	`NCT03196258` - Cognitive Behavioural Therapy to Reduce Persistent Post-Surgical Pain After Fracture	N/A
Not yet recruiting	`NCT06400732` - Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System
Not yet recruiting	`NCT03141502` - The New Skin Stretching Device for Treatment of Limb Tension Wounds	Phase 4
Terminated	`NCT02400112` - Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures	Phase 4
Recruiting	`NCT00870064` - The Treatment of Type I Open Fractures in Pediatrics	N/A
Recruiting	`NCT04730739` - FastFrame Knee Spanning and Damage Control Kit PMCF	N/A
Completed	`NCT04872400` - Acute Application of Antibiotic Powder in Open Fracture Wounds	Phase 4
Recruiting	`NCT04299022` - Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
Terminated	`NCT03705962` - Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures	Phase 3
Terminated	`NCT03673358` - Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Pilot	N/A
Recruiting	`NCT04274530` - Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial	N/A
Recruiting	`NCT04964947` - Tobramycin Injection to Prevent Infection in Open Fractures	Phase 3
Recruiting	`NCT06130397` - AI Assisted Detection of Fractures on X-Rays (FRACT-AI)
Recruiting	`NCT05260463` - LOQTEQ® Antibacterial Pre-Market Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.